Psagot Value Holdings’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-100
Closed -$14K 560
2022
Q4
$14K Hold
100
﹤0.01% 315
2022
Q3
$14K Hold
100
﹤0.01% 303
2022
Q2
$13K Buy
+100
New +$17K ﹤0.01% 261
2017
Q1
Sell
-12
Closed -$7K 356
2016
Q4
$7K Buy
12
+8
+200% +$6.01K ﹤0.01% 316
2016
Q3
$4K Buy
+4
New +$3.3K ﹤0.01% 337

Other funds holding LABU

Psagot Value Holdings's LABU Position: Q1 2023 in Review

Psagot Value Holdings sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q1 2023, closing a stake of 100 shares — an estimated $14K sold.

Psagot Value Holdings first reported a position in LABU in Q3 2016 and held it in 5 quarters. The position peaked at $14K in Q4 2022. 57 funds tracked by Wall St. Rank hold LABU as of Q1 2023.

  • Psagot Value Holdings reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q1 2023 after selling out during the quarter.
  • Psagot Value Holdings sold 100 Direxion Daily S&P Biotech Bull 3X ETF shares in Q1 2023, an estimated $14K.
  • Psagot Value Holdings first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q3 2016 and held it in 5 quarters.
  • Psagot Value Holdings's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $14K in Q4 2022.
  • 57 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q1 2023.

Based on Psagot Value Holdings's 13F filing for Q1 2023, filed 20 Jun 2023.